Akari Therapeutics Plc ($AKTX)
Filing Information
| Accession Number | 0001493152-26-030207 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 26, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
21,063
Total Value
$0.00
P&L
+inf% (+$242,224.50)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Stock Option (Right to Buy) | Derivative | Jun 24, 2026 | Grant/Award | 5,500 | $0.00 | $0.00 | 5,500 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 24, 2026 | Grant/Award | 15,563 | $0.00 | $0.00 | 15,563 | Direct | โ | View Details |